Abstract
Background A 24-year-old white male was diagnosed as having Crohn's disease by clinical, endoscopic and histological assessments, and long-term remission was successfully induced with short-course prednisolone. While the Crohn's disease was still in remission, the patient presented with cholestasis and hyperbilirubinemia but normal alanine aminotransferase levels, negative results for serological tests for infectious causes of hepatopathy and normal γ-globulin levels.
Investigations Repeated laboratory and serological tests, ultrasonography, endoscopic retrograde cholangiopancreatographies, CT scan, magnetic resonance cholangiopancreatography and liver biopsies.
Diagnosis Autoimmune hepatitis–primary sclerosing cholangitis (AIH–PSC) overlap syndrome on the background of PSC with a rare course of sequential manifestations of the different disease components.
Management Combined immunosuppression with prednisolone and treatment with ursodeoxycholic acid (UDCA), endoscopic treatment of dominant stenoses, bile duct stent implantation, and close follow-up.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Beuers U and Rust C (2005) Overlap syndromes. Semin Liver Dis 25: 311–320
Van Buuren HR et al. (2000) High prevalence of autoimmune hepatitis among patients with primary sclerosing cholangitis. J Hepatol 33: 543–548
Kaya M et al. (2000) Overlap of autoimmune hepatitis and primary sclerosing cholangitis: an evaluation of a modified scoring system. J Hepatol 33: 537–542
Abdo AA et al. (2002) Evolution of autoimmune hepatitis to primary sclerosing cholangitis: a sequential syndrome. Hepatology 36: 1393–1399
Hong-Curtis J et al. (2004) Rapid progression of autoimmune hepatitis in the background of primary sclerosing cholangitis. J Clin Gastroenterol 38: 906–909
Domschke WR et al. (2000) Sequential occurrence of primary sclerosing cholangitis and autoimmune hepatitis type III in a patient with ulcerative colitis: a follow up study over 14 years. Liver 20: 340–345
Gregorio GV et al. (2001) Autoimmune hepatitis/sclerosing cholangitis overlap syndrome in childhood: a 16-year prospective study. Hepatology 33: 544–553
Boberg KM et al. (1996) Features of autoimmune hepatitis in primary sclerosing cholangitis: an evaluation of 114 primary sclerosing cholangitis patients according to a scoring system for the diagnosis of autoimmune hepatitis. Hepatology 23: 1369–1376
Chapman RW (1991) Role of immune factors in the pathogenesis of primary sclerosing cholangitis. Semin Liver Dis 11: 1–4
Czaja AJ et al. (2001) Shared genetic risk factors in autoimmune liver disease. Dig Dis Sci 46: 140–147
Floreani A et al. (2005) Clinical course and outcome of autoimmune hepatitis/primary sclerosing cholangitis overlap syndrome. Am J Gastroenterol 100: 1516–1522
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Sander, L., Koch, A., Gartung, C. et al. Lessons from a patient with an unusual hepatic overlap syndrome. Nat Rev Gastroenterol Hepatol 4, 635–640 (2007). https://doi.org/10.1038/ncpgasthep0954
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/ncpgasthep0954